We are aware some users might find it difficult to log into our site today. We are working on this issue and hope to have it resolved shortly.

Learning disability nurses need to get involved with the ethical debate on prenatal testing

The availability of non-invasive prenatal testing has opened the debate about over-medicalising Down’s and other syndromes.
Prenatal screening

Nuffield Council on Bioethics has published a nine-month ethical review of the use of non-invasive prenatal testing (NIPT) prompted by availability of screening for genetic conditions in the private sector, and the possible future uses of technology to identify possible post-birth characteristics.

NIPT is a new technology that can identify and, in some cases, diagnose some genetic conditions and variations via a blood test rather than using invasive tests such as amniocentesis or chorionic villus sampling. In the case of Down’s, Edward’s and Patau’s syndromes, the new test is not sensitive enough to confirm a diagnosis, but it can produce a better estimate of the chances a woman has of carrying a child with those labels/conditions. NIPT


Want to read more?

Unlock full access to RCNi Plus today

Save over 50% on your first three months:

  • Customisable clinical dashboard featuring 200+ topics
  • Unlimited online access to all 10 RCNi Journals including Learning Disability Practice
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • NMC-compliant RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests

This article is not available as part of an institutional subscription. Why is this?